Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?
- PMID: 22146482
- DOI: 10.1016/j.jcf.2011.11.004
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?
Abstract
Background: Transmissible Pseudomonas aeruginosa (Psa) strains such as the Liverpool Epidemic Strain (LES) are now widespread throughout UK CF clinics: their susceptibility to antibiotics is therefore important. To study this, we compared antibiogram patterns of Psa strains in our CF clinic over 5 years, looking at differences in resistance patterns between strains and changes to these over time.
Methods: The antibiograms of sputum samples between 2004 and 2008 from patients attending our centre were included. We compared Psa isolate antibiotic resistance (to six anti-pseudomonal antibiotics) patterns for patients infected with LES with those infected with other Psa strains, both in the total population in 2004 (125 patients) and 2008 (166 patients) and also longitudinally from annual review samples 2004 to 2008 in matched and unmatched patient groups.
Results: LES exhibited significantly more resistant isolates in 2004 (p<0.0001). There was an increase in antibiotic resistance in both LES and other Psa strains over time (p<0.001). Cox proportional hazards analysis of both unmatched (n=125) and matched (n=56) patients in 2004 revealed that LES infected patients were more likely to develop antibiotic resistant isolates over time (hazard ratio 8.1, p<0.001). Fewer LES isolates were classed as fully sensitive in both matched and unmatched groups at the end of study period (p<0.001).
Conclusion: This study shows a worrying trend in antibiotic resistance in the Psa isolates amongst patients chronically infected with LES. This highlights the need to prevent cross infection through segregation and also the need to develop new strategies to treat these organisms.
Copyright © 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x. Respirology. 2008. PMID: 18811887
-
Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.JAMA. 2010 Nov 17;304(19):2145-53. doi: 10.1001/jama.2010.1665. JAMA. 2010. PMID: 21081727
-
Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.Microb Genom. 2018 Mar;4(3):e000167. doi: 10.1099/mgen.0.000167. Epub 2018 Mar 16. Microb Genom. 2018. PMID: 29547097 Free PMC article.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
The increasing threat of Pseudomonas aeruginosa high-risk clones.Drug Resist Updat. 2015 Jul-Aug;21-22:41-59. doi: 10.1016/j.drup.2015.08.002. Epub 2015 Aug 10. Drug Resist Updat. 2015. PMID: 26304792 Review.
Cited by
-
Developing an international Pseudomonas aeruginosa reference panel.Microbiologyopen. 2013 Dec;2(6):1010-23. doi: 10.1002/mbo3.141. Epub 2013 Nov 11. Microbiologyopen. 2013. PMID: 24214409 Free PMC article.
-
Novel application of metagenomics for the strain-level detection of bacterial contaminants within non-sterile industrial products - a retrospective, real-time analysis.Microb Genom. 2022 Nov;8(11):mgen000884. doi: 10.1099/mgen.0.000884. Microb Genom. 2022. PMID: 36748522 Free PMC article.
-
Transmission, adaptation and geographical spread of the Pseudomonas aeruginosa Liverpool epidemic strain.Microb Genom. 2021 Mar;7(3):mgen000511. doi: 10.1099/mgen.0.000511. Epub 2021 Mar 15. Microb Genom. 2021. PMID: 33720817 Free PMC article.
-
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.Antimicrob Agents Chemother. 2016 Oct 21;60(11):6735-6741. doi: 10.1128/AAC.01046-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27572406 Free PMC article.
-
Coming of age in cystic fibrosis - transition from paediatric to adult care.Clin Med (Lond). 2013 Oct;13(5):482-6. doi: 10.7861/clinmedicine.13-5-482. Clin Med (Lond). 2013. PMID: 24115706 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous